Bill Text: NY A05914 | 2023-2024 | General Assembly | Amended

---

Bill Title: Designates Xylazine as a schedule III depressant.

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Introduced) 2024-01-03 - referred to health [A05914 Detail]

Download: New_York-2023-A05914-Amended.html

---

                STATE OF NEW YORK
        ________________________________________________________________________

                                         5914--A

                               2023-2024 Regular Sessions

                   IN ASSEMBLY

                                     March 24, 2023
                                       ___________

        Introduced  by M. of A. WOERNER -- read once and referred to the Commit-
          tee on Health -- committee discharged, bill amended, ordered reprinted
          as amended and recommitted to said committee

        AN ACT to amend the public health law, in relation to designating  Xyla-
          zine as a schedule III depressant

          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:

     1    Section 1. Subdivision (c) of schedule III  of  section  3306  of  the
     2  public  health  law  is  amended by adding a new paragraph 15 to read as
     3  follows:
     4    (15)  Xylazine  (N-(2,6-dimethylphenyl)-5,6-dihydro-4H-1,3  thiazin-2-
     5  amine),  including  its salts, isomers and salts of isomers whenever the
     6  existence of such salts, isomers and salts of isomers is possible within
     7  the specific chemical designation.
     8    § 2. This act shall take effect on the ninetieth day  after  it  shall
     9  have become a law.






         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD06914-02-3